An antidepressant from the Fifties could treat prostate cancer and reduce side-effects of other treatments.

Results of a small trial suggest that the drug phenelzine, which treats depression (by altering levels of brain chemicals that regulate mood) can shrink tumours in men whose prostate cancer has returned.